(0.14%) 5 161.75 points
(0.12%) 38 878 points
(0.08%) 18 016 points
(0.86%) $78.78
(0.42%) $2.15
(0.97%) $2 331.00
(2.58%) $27.38
(0.45%) $969.65
(0.05%) $0.929
(-0.20%) $10.85
(-0.18%) $0.796
(0.10%) $91.54
3 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 3.95%
-3.37% $ 0.430
Live Chart Being Loaded With Signals
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America...
Stats | |
---|---|
Tagesvolumen | 5 317.00 |
Durchschnittsvolumen | 75 466.00 |
Marktkapitalisierung | 119.79M |
EPS | $0 ( 2024-03-25 ) |
Nächstes Ertragsdatum | ( $0 ) 2024-05-09 |
Last Dividend | $0.120 ( 2011-12-19 ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.17 |
ATR14 | $0 (0.00%) |
Spectral Medical Inc Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Spectral Medical Inc Finanzdaten
Annual | 2023 |
Umsatz: | $1.60M |
Bruttogewinn: | $-4.81M (-301.06 %) |
EPS: | $-0.0562 |
FY | 2023 |
Umsatz: | $1.60M |
Bruttogewinn: | $-4.81M (-301.06 %) |
EPS: | $-0.0562 |
FY | 2022 |
Umsatz: | $1.67M |
Bruttogewinn: | $983 000 (58.97 %) |
EPS: | $-0.0419 |
FY | 2021 |
Umsatz: | $2.05M |
Bruttogewinn: | $1.22M (59.45 %) |
EPS: | $-0.0300 |
Financial Reports:
No articles found.
Spectral Medical Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.120 | 2011-12-19 |
Last Dividend | $0.120 | 2011-12-19 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.120 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.01 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
XMV.TO | Dividend Junior | 2023-06-26 | Quarterly | 13 | 1.48% | |
QUU.TO | Dividend Knight | 2023-09-18 | Quarterly | 7 | 0.80% | |
FST.TO | Dividend Junior | 2023-06-29 | Quarterly | 8 | 1.10% | |
AIF.TO | Dividend Knight | 2023-09-28 | Quarterly | 17 | 0.65% | |
VE.TO | Dividend Junior | 2023-06-30 | Quarterly | 11 | 1.75% | |
MUB.TO | Dividend Knight | 2023-09-01 | Monthly | 9 | 2.32% | |
DIR-UN.TO | Dividend King | 2023-07-28 | Monthly | 11 | 2.82% | |
YXM.TO | No Dividend Player | 2023-09-22 | Annually | 12 | 0.42% | |
SAP.TO | Dividend King | 2023-09-01 | Quarterly | 27 | 1.31% | |
HCG.TO | Dividend Knight | 2023-08-30 | Annually | 21 | 0.58% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -9.76 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -2.99 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | 1.629 | 1.500 | 10.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.403 | 0.800 | -2.99 | -2.39 | [1 - 3] |
quickRatioTTM | 0.366 | 0.800 | -2.55 | -2.04 | [0.8 - 2.5] |
cashRatioTTM | 0.288 | 1.500 | 9.51 | 10.00 | [0.2 - 2] |
debtRatioTTM | 1.547 | -1.500 | 10.00 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -8.77 | 1.000 | -4.36 | -4.36 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.0385 | 2.00 | -0.0128 | -0.0257 | [0 - 30] |
freeCashFlowPerShareTTM | -0.0391 | 2.00 | -0.0196 | -0.0391 | [0 - 20] |
debtEquityRatioTTM | -0.487 | -1.500 | -1.948 | 2.92 | [0 - 2.5] |
grossProfitMarginTTM | -0.321 | 1.000 | -8.68 | -8.68 | [0.2 - 0.8] |
operatingProfitMarginTTM | -7.32 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -1.330 | 1.000 | -8.50 | -8.50 | [0.2 - 2] |
assetTurnoverTTM | 0.307 | 0.800 | -1.289 | -1.031 | [0.5 - 2] |
Total Score | -3.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -7.68 | 1.000 | -0.876 | 0 | [1 - 100] |
returnOnEquityTTM | 1.629 | 2.50 | 10.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.0391 | 2.00 | -0.0130 | -0.0391 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.0385 | 2.00 | -0.0128 | -0.0257 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0536 | 1.500 | -2.98 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -6.71 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -0.539 |
Spectral Medical Inc
Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.